-
1
المؤلفون: Egbert F. Smit, Buge Oz, Lukas Bubendorf, Stephen P. Finn, Lukas C. Heukamp, M. van den Heuvel, I. Marondel, A.O Grady, John R. Gosney, Anders Mellemgaard, Fabrice Duplaquet, Idris Bahce, Sayed M.S. Hashemi, Birgit Weynand, Xavier Durando, S.M.S. Samii, Patrick Pauwels, Pieter E. Postmus, Kim Monkhorst, Frédérique Penault-Llorca, S. Duin, Monika G. Looijen-Salamon, M.A. van der Drift, Ernst-Jan M. Speel, Wim Timens, Reinhard Buettner, N. Akyurek, Birgit I. Lissenberg-Witte, Erik Thunnissen, Birgit Guldhammer Skov, Ed Schuuring, Jens Benn Sørensen, Juergen Wolf, A.J. de Langen, Anne-Marie C. Dingemans
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (MGD) Service d'anatomie pathologique, UCL - (MGD) Service de pneumologie, Pathology, Epidemiology and Data Science, APH - Methodology, CCA - Cancer Treatment and quality of life, Pulmonary medicine
المصدر: Lung cancer: journal of the International Association for the Study of Lung Cancer
Lung Cancer, 138, pp. 13-18
Lung Cancer, 138, 13-18
Lung Cancer
Lung Cancer, 138, 13-18. ELSEVIER IRELAND LTD
Thunnissen, E, Lissenberg-Witte, B I, van den Heuvel, M M, Monkhorst, K, Skov, B G, Sørensen, J B, Mellemgaard, A, Dingemans, A M C, Speel, E J M, de Langen, A J, Hashemi, S M S, Bahce, I, van der Drift, M A, Looijen-Salamon, M G, Gosney, J, Postmus, P E, Samii, S M S, Duplaquet, F, Weynand, B, Durando, X, Penault-Llorca, F, Finn, S, Grady, A O, Oz, B, Akyurek, N, Buettner, R, Wolf, J, Bubendorf, L, Duin, S, Marondel, I, Heukamp, L C, Timens, W, Schuuring, E M D, Pauwels, P & Smit, E F 2019, ' ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib ', Lung Cancer, vol. 138, pp. 13-18 . https://doi.org/10.1016/j.lungcan.2019.09.023Test
Lung Cancer, 138, 13-18. Elsevier Ireland Ltd
Lung cancer, Vol. 138, p. 13-18 (2019)مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, INTERNATIONAL-ASSOCIATION, Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13], 0302 clinical medicine, alk, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Prospective Studies, In Situ Hybridization, Fluorescence, Gene Rearrangement, fluorescence in situ hybridisation, medicine.diagnostic_test, treatment, REARRANGEMENT, Middle Aged, OF-AMERICAN-PATHOLOGISTS, Prognosis, Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3], Immunohistochemistry, PREVALENCE, Survival Rate, LUNG-CANCER PATIENTS, Treatment Outcome, 030220 oncology & carcinogenesis, immunohistochemistry, Fish
, Female, Non small cell, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], 03 medical and health sciences, MOLECULAR TESTING GUIDELINE, All institutes and research themes of the Radboud University Medical Center, Crizotinib, Internal medicine, Biopsy, medicine, Humans, Protein Kinase Inhibitors, non-small cell lung cancer, business.industry, ADENOCARCINOMA, Treatment, 030104 developmental biology, COPY NUMBER, ALK, KINASE INHIBITORS GUIDELINE, Fluorescence in situ hybridisation, Human medicine, prognosis, business, Stage iv, Fluorescence in situ hybridization, IHC وصف الملف: pdf; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbd4c2857be1034f64d88d9f7a78b17Test
https://doi.org/10.1016/j.lungcan.2019.09.023Test -
2
المؤلفون: Ernst-Jan M. Speel, Nils A. 't Hart, B. E. van den Borne, E. Van Der Heijden, Monika G. Looijen-Salamon, S. Riemersma, Lizza E.L. Hendriks, A. J. van der Wekken, Harry J.M. Groen, Ed Schuuring, Wim Timens, R. Pelgrim, A. Van Den Berg, Thijo J N Hiltermann, A.J. de Langen, N Werner, J. Staal-van den Brekel, Anne-Marie C. Dingemans, M. F. Mastik
المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Translational Immunology Groningen (TRIGR), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), CCA - Cancer Treatment and quality of life, Pulmonary medicine, Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Pathologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie
المصدر: Clinical Cancer Research, 23(15), 4251-4258. AMER ASSOC CANCER RESEARCH
Europe PubMed Central
Clinical Cancer Research, 23(15), 4251-4258. American Association for Cancer Research Inc.
Clinical Cancer Research, 23, 4251-4258
Clinical Cancer Research, 23, 15, pp. 4251-4258
Van Der Wekken, A J, Pelgrim, R, T Hart, N, Werner, N, Mastik, M F, Hendriks, L, Van Der Heijden, E H F M, Looijen-Salamon, M, De Langen, A J, Staal-Van Den Brekel, J, Riemersma, S, Van Den Borne, B E, Speel, E J M, Dingemans, A M C, Hiltermann, T J N, Van Den Berg, A, Timens, W, Schuuring, E & Groen, H J M 2017, ' Dichotomous ALK-IHC is a better predictor for ALK inhibition outcome than traditional ALK-FISH in advanced non–small cell lung cancer ', Clinical Cancer Research, vol. 23, no. 15, pp. 4251-4258 . https://doi.org/10.1158/1078-0432.CCR-16-1631Testمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, Pyridines, FUSION, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, GENE REARRANGEMENT, In Situ Hybridization, Fluorescence, CRIZOTINIB THERAPY, medicine.diagnostic_test, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, CARCINOMAS, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Adult, medicine.medical_specialty, Biopsy, Fine-Needle, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Disease-Free Survival, 03 medical and health sciences, Crizotinib, Internal medicine, Biopsy, Biomarkers, Tumor, medicine, Carcinoma, Humans, IMMUNOHISTOCHEMISTRY, Lung cancer, Aged, IDENTIFICATION, business.industry, Receptor Protein-Tyrosine Kinases, Cancer, ADENOCARCINOMA, Gene rearrangement, IN-SITU HYBRIDIZATION, medicine.disease, COPY NUMBER, 030104 developmental biology, Pyrazoles, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294301d2488887f96efb73185cf8e257Test
https://doi.org/10.1158/1078-0432.ccr-16-1631Test -
3
المؤلفون: Tineke W.H. Meijer, Johan Bussink, Johannes H.A.M. Kaanders, Erik H.F.M. van der Heijden, Monika G. Looijen-Salamon, Wim J.G. Oyen, Eric P. Visser, Paul N. Span, Miep A. van der Drift, Lioe-Fee de Geus-Oei, Olga C.J. Schuurbiers
المصدر: Journal of Thoracic Oncology, 9, 10, pp. 1485-93
Journal of Thoracic Oncology, 9, 1485-93مصطلحات موضوعية: Male, Pathology, Lung Neoplasms, Cell, Muscle Proteins, Hypoxia-related markers, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Carbonic Anhydrases, Glucose Transporter Type 1, 18-Fluoro-2-deoxyglucose positron emission tomography, biology, Symporters, Middle Aged, Prognosis, Cell Hypoxia, 3. Good health, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], medicine.anatomical_structure, Real-time polymerase chain reaction, Monocarboxylate transporter 1, Oncology, Tumor microenvironment, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Pulmonary and Respiratory Medicine, Monocarboxylic Acid Transporters, medicine.medical_specialty, Adenocarcinoma of Lung, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Disease-Free Survival, 03 medical and health sciences, Antigens, Neoplasm, Fluorodeoxyglucose F18, medicine, Carcinoma, Humans, Carbonic Anhydrase IX, Aged, Neoplasm Staging, business.industry, Non–small-cell lung cancer, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Histology, medicine.disease, Tumor glucose metabolism, Glucose, Positron-Emission Tomography, biology.protein, GLUT1, Radiopharmaceuticals, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5eed41c598b0564cec9ac0cca5119dTest
https://doi.org/10.1097/JTO.0000000000000286Test